By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Johnson & Johnson 

1 Johnson & Johnson Plaza

New Brunswick  New Jersey  08933  U.S.A.
Phone: 732-524-0400 Fax: 732-524-3300


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Alliance Pharmaceutical Corp.  Oxygent ™ co-development

Medarex, Inc.  Broad HuMAb-Mouse antibody development agreement.

Incyte 

Genetronics, Inc.  On October 6, 1998 Genetronics entered into comprehensive development and license agreements involving its proprietary drug delivery system for Electroporation Therapy treatment of cancer with Ethicon, Inc., a Johnson & Johnson company

Essential Therapeutics, Inc.   Cephalosporin which is currently in pre-clinical stages - and will target Staphylococcal infections, Enterococcal infections, and Streptococcus pneumoniae infections.

Pharmagene Laboratories Limited 

Amersham Biosciences 

Bristol-Myers Squibb 

PanVera LLC 

Rigel 

Massachusetts Life Sciences Center 





Company News
Johnson & Johnson (JNJ) To Participate In RBC Capital Markets Global Healthcare Conference 2/9/2016 8:21:42 AM
Ex-FDA Head Accused of Conspiring to Suppress Information About Harmful Effects of Johnson & Johnson (JNJ) Antibiotic 2/9/2016 6:59:56 AM
Johnson & Johnson (JNJ) to Transition Select Operations and Staff from Memphis Distribution Center to FedEx 2/9/2016 6:38:39 AM
Johnson & Johnson (JNJ) And Big Pharma Could Find A Diabetes "Cure" With PharmaCyte (PMCB) Biotech's Type 1 Diabetes Treatment 2/8/2016 12:06:13 PM
Johnson & Johnson (JNJ) Falls as FDA Staffers Back Celltrion (068270.KQ)'s Remicade Biosimilar 2/8/2016 6:15:00 AM
Cue Announces Collaboration With Johnson & Johnson (JNJ) And Johnson & Johnson Innovation (JNJ) To Accelerate Development Of Quantitative HIV Viral Load Test For Resource Poor Settings 2/4/2016 11:15:59 AM
Johnson & Johnson (JNJ) Hands Over In-House Rival BetaLogics to ViaCyte, Gives Updates on Stem Cell Diabetes Trial 2/4/2016 5:55:38 AM
Big Names Like Johnson & Johnson (JNJ), Merck & Co. (MRK) and Pfizer (PFE) Evaluate Technologies and Existing Vaccines for Ways to Fight Zika 2/3/2016 5:54:24 AM
The Institute of Cancer Research, London Sells A Portion Of Its Royalty Entitlement Relating To Sales Of Johnson & Johnson (JNJ)’s Zytiga To Dri Capital Managed Fund 2/2/2016 11:01:36 AM
Johnson & Johnson (JNJ)'s Ethicon (JNJ) Recalls Gynecare Thermachoice III Cath on Shelf Life Issues 2/2/2016 7:23:11 AM
12345678910...
//-->